New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
cbdMD, Inc.
YCBD
Shape
US Flag

AMEX

Unprofitable

EPS improving

Unprofitable

EPS improving

2M

Drug Manufacturers - Specialty & Generic

Next Earning date - 20 Dec 2024

2M

Drug Manufacturers - Specialty & Generic

Next Earning date - 20 Dec 2024

0.46USD
Shape0.01 ( 1.97%)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

-10%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

73%

Quote Panel

Shape
Updated October 4, 2024
1W -2.13 % 1M -16.43 % 3M -17.99 % 1Y -53.54 %

Key Metrics

Shape
  • Market Cap

    1.73M


  • Shares Outstanding

    3.76M


  • Share in Float

    3.12M


  • Dividende

    0


  • Earning Date

    20 Dec 2024


  • Price Target

    0.46


  • Average Volume

    30506


  • Beta

    2.016


  • Range

    0.44-1.73


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cbdmd.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.08x

P/S Ratio

0.55x

P/B Ratio

0.8

Debt/Equity

-99.0%

Net Margin

$-10.9

EPS

How YCBD compares to sector?

P/E Ratio

Relative Strength

Shape

YCBD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$22M

Shape317%

2025-Revenue

$0.89

Shape-493%

2025-EPS

$4M

Shape1687%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-11.26
vs -1.80

Q4.22

arrow
arrow

N/A

-3.60
vs -1.80

Q1.23

arrow
arrow

N/A

-1.74
vs -4.50

Q2.23

arrow
arrow

N/A

-1.16
vs -0.90

Q3.23

arrow
arrow

N/A

-9.06
vs -11.26

Q4.23

arrow
arrow

N/A

-0.67
vs -3.60

Q1.24

arrow
arrow

N/A

-1.35
vs -1.74

Q2.24

arrow
arrow

N/A

-0.15
vs -1.16

Q3.24

arrow
arrow

N/A

-0.45
vs -9.06

Q4.24

arrow
arrow

N/A

-0.37
vs -0.67

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-20%

7.9M  vs 9.8M

Q4.22

arrow
arrow

-35%

6.1M  vs 9.3M

Q1.23

arrow
arrow

-35%

6.2M  vs 9.6M

Q2.23

arrow
arrow

-29%

6.1M  vs 8.6M

Q3.23

arrow
arrow

-27%

5.7M  vs 7.9M

Q4.23

arrow
arrow

-12%

5.4M  vs 6.1M

Q1.24

arrow
arrow

-30%

4.4M  vs 6.2M

Q2.24

arrow
arrow

-15%

5.2M  vs 6.1M

Q3.24

arrow
arrow

-16%

4.8M  vs 5.7M

Q4.24

arrow
arrow

-3%

5.2M  vs 5.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-50%

-0.50
vs -0.70

Q4.22

arrow
arrow

-19%

-0.19
vs -0.50

Q1.23

arrow
arrow

+235%

2.35
vs -0.19

Q2.23

arrow
arrow

-7%

-0.07
vs 2.35

Q3.23

arrow
arrow

-176%

-1.76
vs -0.07

Q4.23

arrow
arrow

-14%

-0.14
vs -1.76

Q1.24

arrow
arrow

-130%

-1.30
vs -0.14

Q2.24

arrow
arrow

+15%

0.15
vs -1.30

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

62

62
vs 66

-6%

Q4.21

arrow
arrow

53

53
vs 62

-15%

Q1.22

arrow
arrow

50

50
vs 53

-6%

Q2.22

arrow
arrow

52

52
vs 50

4%

Q3.22

arrow
arrow

43

43
vs 52

-17%

Q4.22

arrow
arrow

44

44
vs 43

2%

Q1.23

arrow
arrow

43

43
vs 44

-2%

Q2.23

arrow
arrow

2

2
vs 43

-95%

Earnings Growth

Latest News